etizolam

06/01/2011 - "Etizolam was effective in reducing the pain for only about 30 minutes. "
10/01/2019 - "Successful treatment of refractory dermal pain with etizolam and clonazepam in a patient with acquired idiopathic generalized anhidrosis."

02/01/1992 - "These results allow us to conclude that etizolam is effective and safe for the treatment of essential hypertension accompanied with unspecified complaints."
02/01/1992 - "We assessed the efficacy of etizolam (an antianxiety drug) in 18 patients with essential hypertension accompanied with unspecified complaints. "
02/01/1992 - "The efficacy of additive use of etizolam in patients with essential hypertension and unspecified complaints."

12/01/2009 - "The primary aim of this study was to test for the noninferiority of etizolam 0.5 mg BID versus placebo in affecting cognitive function in patients with mild to moderate anxiety disorder of recent onset (<1 month). "
01/01/1990 - "A double-blind, placebo-controlled study was carried out in 36 patients diagnosed as suffering from Generalized Anxiety Disorder with associated depressive symptoms to assess the efficacy and tolerability of two unitary doses of etizolam. "
12/01/2009 - "Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder."
01/01/1990 - "Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo."
09/01/1989 - "Etizolam in the treatment of generalized anxiety disorder: a controlled clinical trial."

08/01/1987 - "Injection of PAF into the tail veins of mice produced lethal shock within 10-30 min. Etizolam (0.1-3 mg/kg, i.v. and 1-10 mg/kg, p.o.) protected against the lethal effect of PAF (75 micrograms/kg, i.v.) in a dose-dependent manner. "
02/01/1999 - "Further, etizolam inhibited in a dose-dependent manner basal acetylcholine release from both hippocampus and prefrontal cortex, and reversed foot-shock-induced increase of basal acetylcholine release to a control level. "
01/01/1978 - "The increase of the turnover of 5-HT, NE and DA due to foot-shock stress in the rat brain was suppressed by the administration of Y-7131. "
03/01/2016 - "Six hours after overdose of 48 mg tizanidine and 24 mg etizolam, she showed sinus bradycardia and peripheral vascular resistance decreasing shock. "
03/01/2016 - "Six hours after overdose of 48 mg tizanidine and 24 mg etizolam, she showed sinus bradycardia and peripheral vascular resistance decreasing shock. "

01/01/2020 - "All the patients were prescribed etizolam for medical reasons, i.e., anxiety and/or insomnia. "
06/01/1988 - "[Clinical study of etizolam in patients with anxiety and insomnia]."
10/01/2013 - "A 75-year-old man who had undergone left upper lobectomy of the lung exhibited fever and insomnia on postoperative day (POD) 1 and muscle rigidity, autonomic instability, and somnolence on POD2 after epidural administration of droperidol and withdrawal of oral etizolam. "
01/01/2009 - "She showed a depressed mood, insomnia, and general fatigue and was taking sulpiride at 300 mg/day, alprazolam at 1.2 mg/day, zopiclone at 7.5 mg/day, and etizolam at 1 mg/day. "
01/01/2021 - "Randomized controlled trials in healthy volunteers or people with insomnia were included if they reported a standardized on-road driving test, were published in English and included ≥1 group receiving a recommended dose of flunitrazepam, estazolam, triazolam, temazepam, brotizolam, etizolam, alprazolam, lorazepam, zolpidem, eszopiclone, zaleplon, zopiclone, trazodone, ramelteon, lemborexant, or suvorexant. "